Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: In vivo Adenine Base Editing rescues adrenoleukodystrophy in a humanized mouse model

PROVIDER: PRJNA1020620 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26178100.fastq.gz	Fastqsanger.gz
	SRR26178200.fastq.gz	Fastqsanger.gz
	SRR26178300.fastq.gz	Fastqsanger.gz
	SRR26178101.fastq.gz	Fastqsanger.gz
	SRR26178201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 554

Similar Datasets

Base Editing Correction of a Hypertrophic Cardiomyopathy-Causing MYH7 Mutation in Human Cardiomyocytes and Humanized Mice

Project description:The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by mutations in cardiac sarcomeric genes and leads to abnormal heart muscle thickening. Complications of HCM include heart failure, arrhythmia, and sudden cardiac death. The dominant-negative c.1208 G>A (p.R403Q) mutation in b-myosin (MYH7) is a common and well-studied mutation that leads to increased cardiac contractility and HCM onset. Here we identify an adenine base editor (ABE) and single-guide RNA system that can efficiently correct this human pathogenic mutation with minimal off-target and bystander editing. We show that delivery of base editing components rescues pathological manifestations of HCM in iPSC-cardiomyocytes derived from HCM patients and in a humanized mouse model of HCM. Our findings demonstrate the use of base editing to treat inherited cardiac diseases and prompt the further development of ABE-based therapies to correct a variety of monogenic mutations causing cardiac disease.

2022-10-25 | GSE201755 | GEO

Project description:In vivo adenine base editing in an adult mouse model of tyrosinemia

| PRJNA513076 | ENA

Project description:In vivo postnatal base editing rescues hearing in a mouse model of recessive deafness

| PRJNA578156 | ENA

Project description:In vivo base editing extends lifespan of a humanized mouse model of prion disease

| PRJNA1178796 | ENA

Humans mice

Project description:Adenine base editing in an adult mouse model of tyrosinemia

| PRJNA513291 | ENA

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels [RNA-seq]

Project description:The majority of known pathogenic point mutations in the human genome are C•G to T•A substitutions. Adenine base editors (ABEs), comprised of nuclease-impaired Cas9 fused to adenine deaminases, enable direct repair of these mutations, making them promising tools for precision in vivo genome editing therapies. However, prior to application in patients, thorough safety and efficacy studies in relevant model organisms are needed. Here, we apply adenine base editing in vivo in the liver of mice and cynomolgus macaques to install a splice site mutation in PCSK9 and reduce blood low-density lipoprotein (LDL) levels, a well-known risk factor for cardiovascular disease. Intravenous delivery of ABE-encoding mRNA and a locus-specific single guide (sg)RNA utilizing lipid nanoparticle (LNP) technology induce up to 67% editing in the liver of mice and up to 34% editing in the liver of macaques, leading to a reduction of plasma PCSK9 and LDL levels. We observed rapid clearance of ABE mRNA after LNP-mediated delivery, and neither sgRNA-dependent nor sgRNA-independent off-target mutations are detected in genomic DNA. Together, our findings support safety and feasibility of adenine base editing to treat patients with monogenetic liver diseases.

2021-04-13 | GSE168363 | GEO

In vivo adenine base editing of PCSK9 in mice and macaques reduces LDL-cholesterol levels [amplicon-seq]

2021-04-13 | GSE168364 | GEO

Mus musculus

Project description:In vivo photoreceptor base editing rescues the rhodopsin-E150K autosomal-recessive retinitis-pigmentosa mouse model

| PRJNA1129541 | ENA

Project description:Adenine Base Editing in iPSCs

| PRJNA970697 | ENA

Project description:In Vivo Adenine Base Editing Corrects Hutchinson - Gilford Progeria Syndrome

| PRJNA627465 | ENA